SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    JSH Guidelines for the Management of Hepatitis B Virus Infection, Hepatology Research, 2014, 44,
  2. 2
    Hmin Liu, Xbo Wang, Gang Wan, Zyun Yang, Hui Zeng, Telbivudine Versus Entecavir for Nucleos(t)ide-Naive HBeAg-Positive Chronic Hepatitis B, The American Journal of the Medical Sciences, 2014, 347, 2, 131

    CrossRef

  3. 3
    Rifaat Safadi, Qing Xie, Yagang Chen, You-Kuan Yin, Lai Wei, Seong Gyu Hwang, Eli Zuckerman, Ji-Dong Jia, Patricia Lopez, Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine, Liver International, 2011, 31, 5
  4. 4
    Ming-Hua Zheng, Ke-Qing Shi, Zhi-Juan Dai, Chao Ye, Yong-Ping Chen, A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients, Clinical Therapeutics, 2010, 32, 4, 649

    CrossRef

  5. 5
    Zhongjie Shi, Yuebo Yang, Lin Ma, Xiaomao Li, Ann Schreiber, Lamivudine in Late Pregnancy to Interrupt In Utero Transmission of Hepatitis B Virus, Obstetrics & Gynecology, 2010, 116, 1, 147

    CrossRef

  6. 6
    Nao Kurashige, Naoki Hiramatsu, Kazuyoshi Ohkawa, Takayuki Yakushijin, Shinichi Kiso, Tatsuya Kanto, Tetsuo Takehara, Akinori Kasahara, Yoshinori Doi, Akira Yamada, Masahide Oshita, Eiji Mita, Hideki Hagiwara, Toshihiko Nagase, Harumasa Yoshihara, Eijiro Hayashi, Yasuharu Imai, Michio Kato, Takeshi Kashihara, Norio Hayashi, Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B, Journal of Gastroenterology, 2009, 44, 6, 601

    CrossRef

  7. 7
    Masaru Enomoto, Akihiro Tamori, Madoka Toyama Kohmoto, Takehiro Hayashi, Hiroyasu Morikawa, Hisato Jomura, Hiroki Sakaguchi, Daiki Habu, Norifumi Kawada, Susumu Shiomi, Shuhei Nishiguchi, Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomized trial, Hepatology Research, 2008, 38, 9